Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene

Putranto,Endy  Widya; Kinoshita,Rie; Watanabe,Masami; Sadahira,Takuya; Murata,Hitoshi; Yamamoto,Ken‑Ichi; Futami,Junichiro; Kataoka,Ken; Inoue,Yusuke; Winarsa Ruma,I.   Made; Sumardika,I.   Wayan; Youyi,Chen; Kubo,Miyoko; Sakaguchi,Yoshihiko; Saito,Kenji; Nasu,Yasutomo; Kumon,Hiromi; Huh,Nam‑Ho; Sakaguchi,Masakiyo

doi:10.3892/ol.2017.6201

July-2017 Volume 14 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2017 Volume 14 Issue 1

Full Size Image

Article

Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene

Authors:
- Endy Widya Putranto
- Rie Kinoshita
- Masami Watanabe
- Takuya Sadahira
- Hitoshi Murata
- Ken‑Ichi Yamamoto
- Junichiro Futami
- Ken Kataoka
- Yusuke Inoue
- I. Made Winarsa Ruma
- I. Wayan Sumardika
- Chen Youyi
- Miyoko Kubo
- Yoshihiko Sakaguchi
- Kenji Saito
- Yasutomo Nasu
- Hiromi Kumon
- Nam‑Ho Huh
- Masakiyo Sakaguchi
View Affiliations / Copyright

Affiliations: Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700‑8558, Japan, Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700‑8558, Japan, Department of Medical and Bioengineering Science, Okayama University Graduate School of Natural Science and Technology, Okayama 700‑8530, Japan, Department of Life Science, Faculty of Science, Okayama University of Science, Okayama 700‑0005, Japan, Faculty of Science and Technology, Division of Molecular Science, Gunma University, Kiryu, Gunma 376‑8515, Japan, Department of Microbiology, Kitasato University School of Medicine, Sagamihara, Kanagawa 252‑0374, Japan, Niimi College, Niimi, Okayama 718‑8585, Japan
Pages: 1041-1048
|
Published online on: May 17, 2017

https://doi.org/10.3892/ol.2017.6201
Expand metrics +

Abstract

Reduced expression in immortalized cells (REIC)/Dickkopf-3 (Dkk-3) overexpression, induced using an adenovirus (Ad)‑REIC, has been revealed to have a dramatic therapeutic effect on multiple types of cancer. To achieve an improved therapeutic effect from Ad‑REIC on cancer, our group previously developed an enhanced gene expression system, the C‑TSC cassette [cytomegalovirus (CMV)‑RU5' located upstream (C); another promoter unit composed of triple tandem promoters, human telomerase reverse transcriptase (hTERT), simian virus 40 and CMV, located downstream of the cDNA (TSC); plus a polyadenylation (polyA) signal]. When applied to the conventional Ad‑REIC, this novel system induced the development of an enhanced product, Ad‑C‑TSC‑REIC, which exhibited a noticeable anticancer effect. However, there were difficulties in terms of Ad‑C‑TSC‑REIC productivity in HEK293 cells, which are a widely used donor cell line for viral production. Productivity of Ad‑C‑TSC‑REIC was significantly reduced compared with the conventional Ad‑REIC, as the Ad‑C‑TSC‑REIC had a significantly higher ability to induce apoptotic cell death of not only various types of cancer cell, but also HEK293 cells. The present study aimed to overcome this problem by modifying the C‑TSC structure, resulting in an improved candidate: A C‑T cassette (C: CMV‑RU5' located upstream; T: another promoter unit composed of a single hTERT promoter, located downstream of the cDNA plus a polyA signal), which demonstrated gene expression comparable to that of the C‑TSC system. The improved adenovirus REIC/Dkk‑3 product with the C‑T cassette, named Ad‑C‑T‑REIC, exhibited a higher expression level of REIC/Dkk3, similar to that of Ad‑C‑TSC‑REIC. Notably, the vector mitigated the cell death of donor HEK293 cells, resulting in a higher rate of production of its adenovirus. These results indicated that Ad‑C‑T‑REIC has the potential to be a useful tool for application in cancer gene therapy.

View Figures

View References

1	Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y and Namba M: A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun. 268:20–24. 2000. View Article : Google Scholar : PubMed/NCBI
2	Tsuji T, Nozaki I, Miyazaki M, Sakaguchi M, Pu H, Hamazaki Y, Iijima O and Namba M: Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem Biophys Res Commun. 289:257–263. 2001. View Article : Google Scholar : PubMed/NCBI
3	Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH: Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res. 65:9617–9622. 2005. View Article : Google Scholar : PubMed/NCBI
4	Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH and Kumon H: Down-regulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res. 68:8333–8341. 2008. View Article : Google Scholar : PubMed/NCBI
5	Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y, Ochiai K, et al: Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem. 284:14236–14244. 2009. View Article : Google Scholar : PubMed/NCBI
6	Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H and Date H: REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther. 16:65–72. 2009. View Article : Google Scholar : PubMed/NCBI
7	Sakaguchi M, Watanabe M, Kinoshita R, Kaku H, Ueki H, Futami J, Murata H, Inoue Y, Li SA, Huang P, et al: Dramatic increase in expression of a transgene by insertion of promoters downstream of the cargo gene. Mol Biotechnol. 56:621–630. 2014. View Article : Google Scholar : PubMed/NCBI
8	Watanabe M, Sakaguchi M, Kinoshita R, Kaku H, Ariyoshi Y, Ueki H, Tanimoto R, Ebara S, Ochiai K, Futami J, et al: A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector. Oncol Rep. 31:1089–1095. 2014.PubMed/NCBI
9	Abarzua F, Kashiwakura Y, Takaoka M, Watanabe M, Ochiai K, Sakaguchi M, Iwawaki T, Tanimoto R, Nasu Y, Huh NH and Kumon H: An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis. Biochem Biophys Res Commun. 375:614–618. 2008. View Article : Google Scholar : PubMed/NCBI
10	Kim SJ, Lee HS, Shin JH, Kim CG, Jeong S, Park K, Choe H and Lee H: Preferentially enhanced gene expression from a synthetic human telomerase reverse transcriptase promoter in human cancer cells. Oncol Rep. 16:975–979. 2006.PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3'-side of the transgene

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles